BRC-mediated RNAi targeting of USE1 inhibits tumor growth in vitro and in vivo-Reference-Cited by-同舟云学术

BRC-mediated RNAi targeting of USE1 inhibits tumor growth in vitro and in vivo

Published:2020-02 Issue: Volume:230 Page:119630
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Kim Hyejin,Lee Yeon Kyung,Han Kyung Ho,Jeon Hyunsu,Jeong In-ho,Kim Sang-Yeob,Lee Jong Bum,Lee Peter C.W.

Funder

National Research Foundation of Korea

Korea government

National Research Foundation

Ministry of Science & ICT

University of Seoul

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference35 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Tip60-siRNA regulates ABCE1 acetylation to suppress lung cancer growth via activation of the apoptotic signaling pathway;Liang;Exp. Ther. Med.,2019

3. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging;Jin;Nature,2007

4. Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins;Lee;Mol. Cell,2011

5. Association of Uba6-specific-E2 (USE1) with lung tumorigenesis;Kim;Jnci-J. Natl. Cancer Inst.,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA nanostructures for targeted drug delivery and imaging;RNA Biology;2024-03-31

2. Multifunctional rolling circle transcription-based nanomaterials for advanced drug delivery;Biomaterials;2023-10

3. Suppression of Lung Cancer Malignancy by Micellized siRNA through Cell Cycle Arrest;Advanced Healthcare Materials;2023-01-24

4. NUCLEIC ACID–BASED NANOCARRIERS AS DRUG DELIVERY SYSTEM;Nucleic Acids in Medicinal Chemistry and Chemical Biology;2022-12-16

5. The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development;Advanced Drug Delivery Reviews;2022-07